Microalbuminuria in patients with lung cancer

European Journal of Cancer

Volumn 34, Issue 1, 1998, Pages 76-80

  Pedersen, L M ^a   Milman, N ^b  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NONE

Author keywords

Albuminuria; Lung neoplasms; Microalbuminuria; Prevalence; Survival; Urine

Indexed keywords

ALBUMIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; URINALYSIS;

ALBUMINURIA; DENMARK; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0031913757     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)10003-X     Document Type: Article

References (35)

1. 1. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984, 310, 356-360.
2. 2. Mogensen CE. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 1987, 31, 673-689.
3. 3. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as a predictor of vascular disease in non-diabetic subjects. Islington diabetes survey. Lancet 1988, 2, 530-533.
4. 4. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990, 300, 297-300.
5. 5. Sawyer N, Wadsworth J, Wijnen M, Gabriel R. Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J 1988, 296, 1295-1298.
6. 6. Pedersen LM, Milman N. Prevalence and prognostic significance of proteinuria in patients with lung cancer. Acta Oncol 1996, 35, 691-695.
7. 7. Puolijoki H, Mustonen J, Pettersson E, Pasternack A, Lahdensuo A. Proteinuria and haematuria are frequently present in patients with lung cancer. Nephrol Dial Transplant 1989, 4, 947-950.
8. 8. Gosling P, Shearman CP. Increased levels of urinary proteins: markers of vascular permeability? Ann Clin Biochem 1988, 25 (Suppl.), 150-151.
9. 9. Winocour PH. Microalbuminuria. Worth screening for in early morning urine samples in diabetic, hypertensive, and elderly patients. Br Med J 1992, 304, 196-197.
10. 10. Kaplan BS, Klassen J, Gault MH. Glomerular injury in patients with neoplasia. Annu Rev Med 1976, 27, 117-125.
11. 11. Eagen JW, Lewis EJ. Glomerulopathies of neplasia. Kidney Int 1977, 11, 297-306.
12. 12. WHO Histological Typing of Lung Tumours, 2nd edn. Geneva, World Health Organization, 1981.
13. 13. Mountain CF. A new international staging system for lung cancer. Chest 1986, 89, 225-233.
14. 14. Landgraf-Leurs MMC, Modi E, Horn K, Landgraf R. Immunoturbidimetric assay for the determination of microalbuminuria using the Hitachi analyser. J Clin Chem Clin Biochem 1987, 25, 683-687.
15. 15. Marshall SM. Screening for microalbuminuria: which measurement? Diabetic Med 1991, 8, 706-711.
16. 16. WHO Handbook for Reporting Results of Cancer treatment. Publication 48. Geneva, WHO, 1979.
17. 17. Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int 1986, 30, 465-473.
18. 18. Norris SH. Paraneoplastic glomerulopathies. Semin Nephrol 1993, 13, 258-272.
19. 19. Row PG, Cameron JS, Turner DR. Membranous nephropathy: Long-term follow-up and association with neoplasia. Q J Med 1975, 44, 207-239.
20. 20. Couser WG, Wagonfeld JB, Spargo BH, Lewis EJ. Glomerular deposition of tumor antigen in membranous nephropathy associated with colonic carcinoma. Am J Med 1974, 57, 962-970.
21. 21. Lewis MG, Loughridge LW, Phillips TM. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet 1971, 2, 134-135.
22. 22. Pascal RR, Iannaccone PM, Rollwagen FM, Harding TA, Bennett SJ. Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer patients. Cancer Res 1976, 36, 43-47.
23. 23. Davis S, Marquet E, Rambotti P, Sobel HJ. Electron microscopic and immunohistochemical analysis of glomerular deposits in patients with bronchogenic carcinoma. Ultrastruct Pathol 1980, 1, 527-531.
24. 24. Helin H, Pasternack A, Hakala T. Glomerular electron-dense deposits and circulating immune complexes in patients with malignant tumors. Clin Nephrol 1980, 14, 23-30.
25. 25. Beaufils H, Jouanneau C, Chomette G. Kidney and cancer: results of immunofluorescence microscopy. Nephron 1985, 40, 303-308.
26. 26. Baldwin RW, Price MR. Tumor antigens and tumor-host relationships. Annu Rev Med 1976, 27, 151-158.
27. 27. Moorthy AV, Zimmerman SW, Burkholder PN. Nephrotic syndrome in Hodgkin's disease. Am J Med 1976, 61, 471-477.
28. 28. Hopper J. Tumor-related renal lesions. Ann Intern Med 1974, 81, 550-551.
29. 29. Yamauchi H, Linsey MS, Basava CG. Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med 1985, 145, 2061-2063.
30. 30. Ghosh BL, Muerhcke RC. The nephrotic syndrome: a prodrome to lymphoma. Ann Intern Med 1970, 72, 379-382.
31. 31. Costanza ME, Pinn V, Schwartz RS, Nathanson L. Carcino-embryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med 1973, 289, 520-522.
32. 32. Davison AM, Thomson D. Malignancy-associated glomerular disease. In Cameron JS, Davison AM, Grunfeld JP, et al., eds. Oxford Textbook of Clinical Nephrology. New York, Oxford University Press, 1992, 475-486.
33. 33. Winocour PH, Harland J, Millar JP, Laker MF, Alberti KGMM. Microalbuminuria and associated risk factors in the community. Atherosclerosis 1992, 93, 71-81.
34. 34. Haffner SM, Stern MP, Gruber KK, Hazuda HP, Mitchell BD, Patterson JK. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990, 10, 727-731.
35. 35. Osberg I, Chase HP, Garg SK, et al. Effects of storage time and temperature on measurement of small concentrations of albumin in urine. Clin Chem 1990, 36, 1428-1430.